French agency head answers questions on Mediator "manslaughter"
This article was originally published in SRA
Executive Summary
Dominique Maraninchi, the director general of the French medicines agency, the ANSM, has appeared before judges to answer questions relating to the agency's role in the Mediator drug affair, the agency has confirmed. The judges are investigating whether negligence on the part of the agency contributed to "manslaughter and involuntary injury" caused by the Servier drug between 1995 and 2009.
You may also be interested in...
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.
EU Countries Offered Funding To Contribute to African Regulatory Strengthening
Training projects are intended to strengthen the African regulatory environment, boost the capacity of the African Medicines Agency, facilitate regulatory reliance, and increase joint new drug assessments.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.